Article citation: ¿refinements in the techniques of 2-stage breast reconstruction,¿ matthew d.Freeman, bs, rahul vemula, md, rahul rao, ma, tim s.Matatov, md, amy l.Strong, phd, mph, ravi tandon, md, abigail e.Chaffin, md, and david a.Jansen, md, facs, annals of plastic surgery, vol.76, supplement 4, june 2016, pp.S304-s311.The event is a physiological complication and analysis of the device generally does not assist allergan in determining a probable cause for this event.Further information from the senior author, dr.David a.Jansen, regarding the number of allergan devices used in the study, the causality of the reported adverse events, product information, date of explant surgery, name of explant surgeon, and if the explanted devices will be returned was requested.No additional information will be provided as further follow up is not possible as the doctor is unavailable for additional questioning.Device labeling: the following is a list of potential adverse events that may occur with breast implant surgery.The risks include: implant deflation/leakage, additional surgery, capsular contracture, infection, toxic shock syndrome, necrosis, hematoma, seroma, extrusion, breast pain, changes in nipple sensation, changes in breast sensation, dissatisfaction with cosmetic results (wrinkling, folding, displacement, asymmetry, palpability, visibility, ptosis, sloshing), calcific deposits, irritation/inflammation, delayed wound healing, hypertrophic scarring, breast tissue atrophy/chest wall deformity, difficulty/inability in breast feeding, and inability to adequately visualize breast lesions with mammography.In addition to these potential adverse events, there have been concerns with certain systemic diseases.The stresses of the expanding device may induce pressure ischemia and necrosis, especially in tight or thin-skinned areas.Folds in a partially filled tissue expander may also result in thinning and erosion of adjacent tissue.Excessively rapid tissue expansion may compromise the vascularity of the overlying tissue.
|